fda approval for semaglutide π The has approved (Ozempic) to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) FDA Accepts NDA Submission for
Description
[DOI] [PubMed] [Google Scholar] 9.American Diabetes Association 9 Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes2020
Some patients do well on a lower dose
For optimal results, consistency is key
Assess adherence, missed doses, and side effects limiting escalation
Unlike stimulant laxatives, polyethylene glycol is safe for regular use and does not cause dependence
[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Cai X., She M., Xu M., Chen H., Li J., Chen X., Zheng D., Liu J., Chen S., Zhu J., et al
